TRPV1 and bone cancer: For instance, chronic morphine exposure increases TRPV1 expression in the spinal cord, DRG, and sciatic nerve [29,30], whereas blockade of TRPV1 with its antagonist SB366791 potentiates the analgesic effects of systemic morphine in mice with bone cancer [31].